Health productsUpdated Jan 3, 2026Epinephrine Injection USPOfficial source

    Epinephrine Injection USP recall in Canada: Dosage and packaging differences

    Share:

    In plain language

    This recall involves US-authorized Epinephrine Injection USP, 1 mg/10 mL single-dose pre-filled syringes imported into Canada. It's being recalled because there are differences in dosage, packaging, and administration compared to the Canadian-authorized product. Healthcare professionals should be aware of these differences to prevent errors.

    What to do

    • Healthcare professionals should be aware of the differences in this product.
    • Note that the US-authorized product is for intravenous use only.
    • Refer to the outer carton for syringe assembly instructions.
    • Consult the Canadian Product Monograph for proper use information.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Epinephrine Injection USP Solution for injection 1 mg/10 mL (0.1 mg/mL) single-dose Luer-Jet Luer-Lock pre-filled syringe

      Model: NDC: 76329-3318-1, Stock NO. 3318

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the model number

      Model numbers are typically on the product label or packaging.

      Affected models: NDC: 76329-3318-1, Stock NO. 3318

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    This recall involves US-authorized Epinephrine Injection USP, 1 mg/10 mL single-dose pre-filled syringes imported into Canada. It's being recalled because there are differences in dosage, packaging, and administration compared to the Canadian-authorized product. Healthcare professionals should be aware of these differences to prevent errors.

    What should consumers do?

    Healthcare professionals should be aware of the differences in this product. Note that the US-authorized product is for intravenous use only. Refer to the outer carton for syringe assembly instructions. Consult the Canadian Product Monograph for proper use information.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.

    When was this product recalled?

    This product was recalled on August 29, 2024.

    Is the Epinephrine Injection USP brand affected by this recall?

    Yes, Epinephrine Injection USP products are affected by this recall. This recall involves US-authorized Epinephrine Injection USP, 1 mg/10 mL single-dose pre-filled syringes imported into Canada. It's being recalled because there are differences in dosage, packaging, and administration compared to the Canadian-authorized product. Healthcare professionals should be aware of these differences to prevent errors.